2,320
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1)

, , , , &
Pages 601-614 | Received 03 Dec 2020, Accepted 22 Jan 2021, Published online: 10 Feb 2021

References

  • Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma [J]. Lancet. 2013;381(9864):400–412.
  • Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries [J]. World J Gastroenterol. 2015;21(26):7933–7943.
  • Zhang S, Zhou D. Role of the transcriptional coactivators YAP/TAZ in liver cancer [J]. Curr Opin Cell Biol. 2019;61::64–71.
  • Giraud J, Molina-Castro S, Seeneevassen L, et al. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells [J]. Int J Cancer. 2020;146(8):2255–2267.
  • Tang JY, Yu CY, Bao YJ, et al. TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1 [J]. Cell Cycle. 2018;17(1):102–109.
  • Liu Y, Wang G, Yang Y, et al. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner [J]. Oncogene. 2016;35(21):2789–2800.
  • Li Y, Liu S, Ng EY, et al. Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4 [J]. Biochem J. 2018;475(12):2043–2055.
  • Mesrouze Y, Meyerhofer M, Bokhovchuk F, et al. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ [J]. Protein Sci. 2017;26(12):2399–2409.
  • Yoo G, Kim T, Chung C, et al. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization [J]. Biochem Biophys Res Commun. 2017;490(3):650–656.
  • Conza D, Mirra P, Calì G, et al. The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells [J]. J Cell Physiol. 2017;232(12):3735–3743.
  • Ueki S, Fujishima F, Kumagai T, et al. NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy [J]. BMC Cancer. 2020;20(1):161.
  • Zhao B, Ye X, Yu J, et al. TEAD mediates YAP-dependent gene induction and growth control [J]. Genes Dev. 2008;22(14):1962–1971.
  • Jordan T, Mastnak DM, Palamar N, et al. Nutritional therapy for patients with esophageal cancer [J]. Nutr Cancer. 2018;70(1):23–29.
  • Kato H, Nakajima M. Treatments for esophageal cancer: a review [J]. Gen Thorac Cardiovasc Surg. 2013;61(6):330–335.
  • Short MW, Burgers KG, Fry VT, et al. [J]. Am Fam Physician. 2017;95(1):22–28.
  • Sakamoto T, Fujiogi M, Matsui H, et al. Comparing perioperative mortality and morbidity of minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a nationwide retrospective analysis [J]. Ann Surg. 2019. DOI:10.1097/SLA.0000000000003500
  • Chen MF, Yang YH, Lai CH, et al. Outcome of patients with esophageal cancer: a nationwide analysis [J]. Ann Surg Oncol. 2013;20(9):3023–3030.
  • Wang X, Li G, Luo Q, et al. Identification of crucial genes associated with esophageal squamous cell carcinoma by gene expression profile analysis [J]. Oncol Lett. 2018;15(6):8983–8990.
  • He S, Gao K, Mao L, et al. Gene silencing of transcription factor TEAD4 inhibits esophageal cancer cells by regulating TCF7 [J]. Cancer Biother Radiopharm. 2020;10. doi:10.1089/cbr.2020.3870.
  • Zhang W, Li J, Wu Y, et al. TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma [J]. Cancer Cell Int. 2018;18:178.
  • Shuai Y, Ma Z, Liu W, et al. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2 [J]. Mol Cancer. 2020;19(1):6.
  • Wu Y, Zheng Q, Li Y, et al. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells [J]. J Exp Clin Cancer Res. 2019;38(1):376.
  • Liu W, Wang X, Liu Z, et al. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway [J]. Br J Cancer. 2017;117(8):1139–1153.
  • Amato R, D’Antona L, Porciatti G, et al. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation [J]. J Mol Med (Berl). 2009;87(12):1221–1239.
  • Bai JA, Xu GF, Yan LJ, et al. SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK/ERK/p53 pathway in colitis [J]. World J Gastroenterol. 2015;21(20):6180–6193.